Recombinant Human OPG (C-6His)-細胞/細菌培養-試劑-生物在線

女人与狗锁死了视频大全|霍金死亡过程恐怖视频|无节社团简谱季免费观看|六间房直播大厅|中文字幕欧美另类精品|久久人人玩人妻潮喷内射人人|亚洲国产一区二区三区在线观看

生物谷
Recombinant Human OPG (C-6His)

Recombinant Human OPG (C-6His)

商家詢價

產品名稱: Recombinant Human OPG (C-6His)

英文名稱:

產品編號: C325

產品價格: 0

產品產地: 中國

品牌商標: Novoprotein

更新時間: null

使用范圍: null

生物谷
  • 聯系人 : 請聯系郵箱
  • 地址 : 上海市徐匯區光啟城辦公樓3樓
  • 郵編 : 100176
  • 所在區域 : 上海
  • 電話 : business@bioon.com 點擊查看
  • 傳真 : 點擊查看
  • 郵箱 : business@bioon.com

TNFRSF11B is a secreted protein, containing 2 death domains and 4 TNFR-Cys repeats. TNFRSF11B is a decoy receptor for the receptor activator of nuclear factor kappa B ligand (RANKL). By binding RANKL, TNFRSF11B inhibits nuclear kappa B (NF-κB) which is a central and rapid acting transcription factor for immune-related genes, and a key regulator of inflammation, innate immunity, and cell survival and differentiation. TNFRSF11B levels are influenced by voltage-dependent calcium channelsCav1.2. TNFRSF11B can reduce the production of osteoclasts by inhibiting the differentiation of osteoclast precursors (osteoclasts are related to monocytes/macrophages and are derived from granulocyte/macrophage-forming colony units (CFU-GM)) into osteoclasts and also regulates the resorption of osteoclasts in vitroand in vivo. TNFRSF11B binding to RANKL on osteoblast/stromal cells, blocks the RANKL-RANK ligand interaction between osteoblast/stromal cells and osteoclast precursors. This has the effect of inhibiting the differentiation of the osteoclast precursor into a mature osteoclast.